Use of a photoactive derivative of actinomycin to investigate shuffling between binding sites on DNA.

A photoreactive analog of actinomycin (7-azidoactinomycin D) has been used in experiments to probe directly the shuffling hypothesis of Fox and Waring [Fox, K. R., & Waring, M. J. (1984) Nucleic Acids Res. 12, 9271-9285]. According to this theory, actinomycin D molecules initially interact with non-sequence-specific sites on DNA and subsequently "shuffle" along the polymer in a one-dimensional migratory fashion so as to locate their preferred sequence-dependent binding sites. In the study presented here, the drug-DNA complex was allowed to equilibrate (in the dark) for various periods of time, followed by photolysis which renders the complex irreversible and traps the ligand at its instantaneous binding sites. Visualization of the piperidine-labile sites and investigation of how the intensity of reaction at each site changes with time can provide direct confirmation of the shuffling hypothesis. The data reveal that actinomycin D does indeed engage in shuffling along the DNA. After only short equilibration times (20 s) actinomycin D is observed to bind to a variety of sites on the DNA, including many which are not regarded as canonical preferred binding sites at equilibrium. However, after longer periods of equilibration the intensity of reaction is shown to drop as a function of time at nonspecific sites, with corresponding increase at sequence-specific sites. In addition, base sequences which flank the intercalation sites can be seen to play a major role in influencing the binding and sequence specificity of actinomycin.

[1]  J. Richardson.  The binding of RNA polymerase to DNA. , 1966, Journal of molecular biology.

[2]  D M Crothers,et al.  Studies of the binding of actinomycin and related compounds to DNA. , 1968, Journal of molecular biology.

[3]  R. Hyman,et al.  Kinetics of the in vitro inhibition of transcription by actinomycin. , 1970, Journal of molecular biology.

[4]  M. Waring,et al.  Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. , 1970, Journal of molecular biology.

[5]  P. Friedman,et al.  Antibiotics and nucleic acids. , 1971, Annual review of biochemistry.

[6]  H. M. Sobell.  The stereochemistry of actinomycin binding to DNA and its implications in molecular biology. , 1973, Progress in nucleic acid research and molecular biology.

[7]  D. Patel.  Peptide antibiotic-oligonucleotide interactions. Nuclear magnetic resonance investigations of complex formation between actinomycin D and d-ApTpGpCpApT in aqueous solution. , 1974, Biochemistry.

[8]  D. Crothers,et al.  DNA-ethidium reaction kinetics: demonstration of direct ligand transfer between DNA binding sites. , 1975, Journal of molecular biology.

[9]  R. Bittman,et al.  Stopped-flow kinetic studies of actinomycin binding to DNAs. , 1975, Biochemistry.

[10]  K. L. Yielding,et al.  Synthesis, separation and characterization of the mono- and diazide analogs of ethidium bromide. , 1977, Biochimica et biophysica acta.

[11]  M. Waring,et al.  Kinetics of drug-DNA interaction. Dependence of the binding mechanism on structure of the ligand. , 1980, Journal of molecular biology.

[12]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[13]  D. Graves,et al.  Ethidium bromide and its photoreactive analogues: spectroscopic analysis of deoxyribonucleic acid binding properties. , 1981, Biochemistry.

[14]  M. Waring,et al.  DNA modification and cancer. , 1981, Annual review of biochemistry.

[15]  H. Berman,et al.  The structure of a pseudo intercalated complex between actinomycin and the DNA binding sequence d(GpC) , 1982, Nature.

[16]  R. Hertzberg,et al.  Map of distamycin, netropsin, and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA.Fe(II). , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Shafer,et al.  Role of actinomycin pentapeptides in actinomycin-deoxyribonucleic acid binding and kinetics. , 1982, Biochemistry.

[18]  D. Williams,et al.  Proton nuclear overhauser effect study of the structure of an actinomycin D complex with a self-complementary tetranucleoside triphosphate. , 1983, Biochemistry.

[19]  P. Dervan,et al.  Methidiumpropyl-EDTA.Fe(II) and DNase I footprinting report different small molecule binding site sizes on DNA. , 1983, Nucleic acids research.

[20]  J. Vournakis,et al.  Sequence specificity of actinomycin D and Netropsin binding to pBR322 DNA analyzed by protection from DNase I. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Beabealashvilli,et al.  Binding of actinomycin D to DNA revealed by DNase I footprinting , 1983, FEBS letters.

[22]  M. Waring,et al.  DNA structural variations produced by actinomycin and distamycin as revealed by DNAase I footprinting. , 1984, Nucleic acids research.

[23]  S. Brown,et al.  Aqueous solution structure of an intercalated actinomycin D-dATGCAT complex by two-dimensional and one-dimensional proton NMR. , 1984, Biochemistry.

[24]  M. Waring,et al.  Kinetic evidence for redistribution of actinomycin molecules between potential DNA-binding sites. , 1984, European journal of biochemistry.

[25]  M. Waring,et al.  Sequence-specific binding of echinomycin to DNA: evidence for conformational changes affecting flanking sequences. , 1984, Nucleic acids research.

[26]  D. Crothers,et al.  Kinetics and sequence specificity of drug-DNA interactions: an in vitro transcription assay. , 1986, Biochemistry.

[27]  M. Waring,et al.  Footprinting reveals that nogalamycin and actinomycin shuffle between DNA binding sites. , 1986, Nucleic acids research.

[28]  D. Crothers,et al.  Effect of drug-DNA interactions upon transcription initiation at the lac promoter. , 1987, Biochemistry.

[29]  M. Waring,et al.  Footprinting at low temperatures: evidence that ethidium and other simple intercalators can discriminate between different nucleotide sequences. , 1987, Nucleic acids research.

[30]  C. Cantor,et al.  Actinomycin D facilitates transition of AT domains in molecules of sequence (AT)nAGCT(AT)n to a DNAse I detectable alternating structure. , 1987, Nucleic acids research.

[31]  F. Chen.  Binding specificities of actinomycin D to self-complementary tetranucleotide sequences -XGCY-. , 1988, Biochemistry.

[32]  R. L. Jones,et al.  1H and 31P NMR investigations of actinomycin D binding selectivity with oligodeoxyribonucleotides containing multiple adjacent d(GC) sites. , 1988, Biochemistry.

[33]  D. Phillips,et al.  Transcriptional analysis of multisite drug-DNA dissociation kinetics: delayed termination of transcription by actinomycin D. , 1988, Biochemistry.

[34]  P. Borer,et al.  Actinomycin D induced DNase I cleavage enhancement caused by sequence specific propagation of an altered DNA structure. , 1988, Nucleic acids research.

[35]  M. Muller,et al.  Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Zon,et al.  2D NMR investigation of the binding of the anticancer drug actinomycin D to duplexed dATGCGCAT: conformational features of the unique 2:1 adduct. , 1988, Biochemistry.

[37]  F. Chen.  Kinetic and equilibrium binding studies of actinomycin D with some d(TGCA)-containing dodecamers. , 1988, Biochemistry.

[38]  D. Phillips,et al.  Bidirectional transcription footprinting of DNA binding ligands. , 1989, Biochemistry.

[39]  K. Breslauer,et al.  Binding of actinomycin D to DNA: evidence for a nonclassical high-affinity binding mode that does not require GpC sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Shafer,et al.  Binding of actinomycin D to [d(ATCGAT)]2: NMR evidence of multiple complexes. , 1989, Biochemistry.

[41]  R. M. Wadkins,et al.  7-Azidoactinomycin D: a novel probe for examining actinomycin D-DNA interactions. , 1989, The Journal of biological chemistry.

[42]  R. Rill,et al.  7-Azido-actinomycin D: a photoaffinity probe of the sequence specificity of DNA binding by actinomycin D. , 1989, Journal of biomolecular structure & dynamics.

[43]  F. Chen.  Observation of an anomalously slow association kinetics in the binding of actinomycin D to d(CATGGCCATG). , 1990, Biochemistry.

[44]  Quantitative footprinting analysis. Binding to a single site. , 1990, Biochemistry.

[45]  K. Fox,et al.  The effects of actinomycin on the structure of dAn.dTn and (dA-dT)n regions surrounding its GC binding site. A footprinting study. , 1991, The Journal of biological chemistry.

[46]  P. Borer,et al.  Actinomycin D induced DNase I hypersensitivity and asymmetric structure transmission in a DNA hexadecamer. , 1991, Nucleic acids research.

[47]  Secondary (non-GpC) binding sites for actinomycin on DNA. , 1992, Biochimica et biophysica acta.

[48]  D. Suck,et al.  X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 A resolution. , 1992, Journal of molecular biology.

[49]  S. Kamitori,et al.  Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. , 1992, Journal of molecular biology.

[50]  J. Goodisman,et al.  Structural changes and enhancements in DNase I footprinting experiments. , 1992, Biochemistry.

[51]  C. Bailly,et al.  Drug—DNA sequence‐dependent interactions analysed by electric linear dichroism , 1992, Journal of molecular recognition : JMR.

[52]  R. Rehfuss,et al.  Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. , 1992, Biochemistry.

[53]  K. Fox.  Probing the conformations of eight cloned DNA dodecamers; CGCGAATTCGCG, CGCGTTAACGCG, CGCGTATACGCG, CGCGATATCGCG, CGCAAATTTGCG, CGCTTTAAAGCG, CGCGGATCCGCG and CGCGGTACCGCG. , 1992, Nucleic acids research.

[54]  S. Neidle.  Minor‐groove width and accessibility in B‐DNA drug and protein complexes , 1992, FEBS letters.

[55]  M. Waring,et al.  New binding sites for antitumor antibiotics created by relocating the purine 2-amino group in DNA , 1993 .

[56]  N. Boutonnet,et al.  Looking into the grooves of DNA , 1993, Biopolymers.

[57]  R. Rill,et al.  Influence of DNA base sequence on the binding energetics of actinomycin D. , 1993, Biochemistry.

[58]  C. M. Jones,et al.  Dissociation kinetics of actinomycin D from oligonucleotides with hairpin motifs. , 1993, Biochemistry.

[59]  K. Fox,et al.  Visualising the kinetics of dissociation of actinomycin from individual sites in mixed sequence DNA by DNase I footprinting. , 1993, Nucleic acids research.